10/9/2026
The South African Reserve Bank and South African Foreign Exchange Committee have launched the FX Global Code Public Register, a central, publicly accessible repository promoting transparency and adoption of the FX Global Code in South Africa and the SADC region.
10/9/2026
To strengthen EU supply chains and diversify sources of critical raw materials, the European Commission announced today that it has selected 46 new Strategic Projects across 16 Member States.
10/9/2026
ARASIA countries have agreed to share and standardize cultural heritage data to combat the trafficking of cultural artifacts, following a proposal by the International Organization for Migration (IOM) and the United Nations Educational, Scientific and Cultural Organization (UNESCO).
10/9/2026
The UK government has released an update on the implementation of the independent review of employers' role in addressing health-based economic inactivity and promoting healthy workplaces.
10/9/2026
The International Atomic Energy Agency (IAEA) has announced an expansion of its cooperation with countries to support the development of nuclear power, aiming to increase global energy security and reduce greenhouse gas emissions.
10/9/2026
The third edition of the Guinea Economic Update, titled Beyond Mining: Turning Natural Resource Wealth into Private Sector Growth and Jobs, reveals that Guinea's economy expanded by 7.4% in 2025, primarily fueled by a robust export sector, and is expected to continue its growth trajectory in 2026, driven by increased investment in the private sector and job creation initiatives.
10/9/2026
The International Atomic Energy Agency (IAEA) has completed a long-term operation safety review at Sweden's Oskarshamn Nuclear Power Plant, a key milestone in ensuring the plant's continued safe operation.
10/9/2026
The European Medicines Agency (EMA) has made a decision on a Paediatric Investigation Plan (PIP) for Stelara and ustekinumab, a treatment for musculoskeletal and connective tissue disorders. The decision relates to a modification of an existing PIP application.
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 treatment, Paxlovid, for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 treatment, Paxlovid, for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The International Atomic Energy Agency (IAEA) has completed its mission to provide physical protection advisory services to Pakistan, a move seen as a significant step towards strengthening the country's nuclear security.
10/9/2026
The 25th meeting of the Council for Cooperation on Financial Stability.
10/9/2026
The number of personal and professional trips by EU residents increased by 1.4% in 2025, with 70% of trips being domestic, up from 2024.
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 treatment, Paxlovid, for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The Council for Cooperation on Financial Stability held its twenty-fifth meeting, and the communication was automatically gathered from the source.
10/9/2026
The Cross-Market Operational Resilience Group (CMORG) completed its biennial simulation exercise, SIMEX26, focused on a global cloud services disruption on 8 October 2026.
10/9/2026
European Medicines Agency (EMA) has approved a new proposal for the use of a COVID-19 treatment, developed by pharmaceutical company Pfizer (NYSE: PFE), in patients with severe respiratory disease. The approval is based on a recent clinical trial that showed significant improvements in patient outcomes.
10/9/2026
Fitch, an international ratings agency, has reaffirmed Australia's AAA credit rating, citing the country's strong economic fundamentals and responsible economic management.
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 treatment, Paxlovid, for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The European Medicines Agency has made a decision on a modification to a Paediatric Investigation Plan (PIP) for Fabhalta and Iptacopan, a treatment for Renal and urinary disorders, following an application for change to the existing plan.
10/9/2026
The European Medicines Agency has issued an opinion and decision on a modification to the Paediatric Investigation Plan (PIP) for Inaqovi, a treatment for blood and lymphatic system disorders, as requested by the manufacturer.
10/9/2026
A bird navigating trash in a drainage pipe to the nature's ability to recover after a forest fire these are just two of the winning photos announced today that captured the spirit and ethos of this year's European...
10/9/2026
A bird navigating trash in a drainage pipe to nature's ability to recover after a forest fire these are just two of the winning photos announced today that captured the spirit and ethos of this year's European Environment...
10/9/2026
The European Medicines Agency (EMA) has issued a new proposal for the evaluation of COVID-19 vaccines, following recent concerns over their effectiveness in certain populations. The proposal aims to improve the assessment of vaccine efficacy and safety, and is expected to be discussed by the EMA's Committee for Medicinal Products for Human Use (CHMP) in the coming months.
10/9/2026
The European Medicines Agency has made a decision on a modification to the Paediatric Investigation Plan (PIP) for Agamree and vamorolone, a treatment for congenital, familial, and genetic disorders, following an application for change to the existing plan.
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant development in the fight against the pandemic
10/9/2026
Amendment to the "Price of Eligible Collateral".
10/9/2026
The European Medicines Agency has issued an opinion and decision on a Paediatric Investigation Plan (PIP) for Emgality and Galcanezumab, a modification to an agreed PIP for surgical and medical procedures, following a request from the applicant.
10/9/2026
The Federal Reserve has announced an amendment to its "Prices of Eligible Collateral" policy, which will take effect on January 1, 2024. The updated policy aims to improve the efficiency of the Federal Reserve's collateral management process.
10/9/2026
The European Medicines Agency (EMA) has made a decision on a modification to a Paediatric Investigation Plan (PIP) for Nilemdo, a medication containing bempedoic acid (ETC-1002), which is used to treat metabolism and nutrition disorders. The decision was made in response to a request from the manufacturer to modify the original PIP.
10/9/2026
The Singapore government is taking proactive measures to bolster its response to haze, a persistent air pollution issue affecting the region, following recent concerns and recommendations from various stakeholders, including the National Environment Agency and the Committee on the Environment and Climate Change.
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The European Medicines Agency has issued an opinion and decision on a Paediatric Investigation Plan (PIP) for Aimovig and Erenumab, a therapeutic area of surgical and medical procedures, following a modification application to the agreed PIP.
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
10/9/2026
The European Medicines Agency has issued an opinion and decision on a modification to the Paediatric Investigation Plan for Enerzair Breezhaler, a respiratory medication, following a request from the manufacturer to update the plan.
10/9/2026
The Singapore government has scheduled a meeting with the National Environment Agency (NEA) and the Public Utilities Board (PUB) to discuss the ongoing haze situation in the country, which has been recently exacerbated by forest fires in Indonesia. The committee will review the current air quality index and propose measures to mitigate the effects of the haze on the public health.
10/9/2026
A recent report by the Financial Stability Board found that few jurisdictions have a public sector backstop in place to meet the funding needs of large systemic banks in resolution or failure.
10/9/2026
The Austrian government has established a school to train professionals in managing radiation emergencies, following a proposal by the Ministry of Health, and is scheduled to open in 2024, with the first class expected to start recently.
10/9/2026
The U.S. Commission has scheduled full reviews to determine whether to revoke countervailing duty orders on phosphate fertilizers from Morocco and Russia, as per the Tariff Act of 1930.
10/9/2026
The U.S. International Trade Commission has decided not to review an initial determination to terminate an investigation into DRAM devices and products based on a settlement.
10/9/2026
The U.S. Court of Appeals for the Federal Circuit has vacated the U.S. International Trade Commission's final determination in the Certain Hydrodermabrasion Systems and Components Thereof investigation due to patent expiration.
10/9/2026
The U.S. Nuclear Regulatory Commission will convene a virtual meeting of the Advisory Committee on the Medical Uses of Isotopes on October 26-27, 2026, to discuss agenda items.
10/9/2026
The U.S. Nuclear Regulatory Commission (NRC) is issuing a draft Environmental Impact Statement (EIS) for public comment in response to a Combined License (COL) application submitted by Fermi America LLC.
10/9/2026
The National Credit Union Administration (NCUA) has approved the publication of a proposal to revise the NCUA Call Report (Form 5300) for public comment, including the collection of new data.
10/9/2026
The U.S. Environmental Protection Agency (EPA) is determining under the Clean Air Act (CAA) that the Berrien County and Muskegon County, Michigan nonattainment areas have attained the 2015 ozone National Ambient Air Quality Standards.
10/9/2026
The U.S. Environmental Protection Agency (EPA) has made available Environmental Impact Statements for various projects.
10/9/2026
The Drug Enforcement Administration published a temporary order placing O-desmethyltramadol in Schedule I on August 12, 2026, correcting a previous action.
10/9/2026
The summary is not available as the source is an automatically generated message.